Wellington Management Group LLP decreased its stake in shares of Varex Imaging Co. (NASDAQ:VREX - Free Report) by 12.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,459,479 shares of the company's stock after selling 201,685 shares during the period. Wellington Management Group LLP owned approximately 3.54% of Varex Imaging worth $21,294,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Wealthfront Advisers LLC bought a new stake in Varex Imaging in the 4th quarter valued at approximately $18,900,000. Geode Capital Management LLC lifted its position in shares of Varex Imaging by 0.5% in the third quarter. Geode Capital Management LLC now owns 929,004 shares of the company's stock worth $11,076,000 after purchasing an additional 4,211 shares in the last quarter. Royce & Associates LP boosted its holdings in Varex Imaging by 70.4% during the fourth quarter. Royce & Associates LP now owns 746,770 shares of the company's stock worth $10,895,000 after purchasing an additional 308,629 shares during the last quarter. Boston Partners bought a new position in Varex Imaging in the fourth quarter valued at $8,718,000. Finally, Jane Street Group LLC grew its position in Varex Imaging by 230.6% in the third quarter. Jane Street Group LLC now owns 551,157 shares of the company's stock valued at $6,570,000 after purchasing an additional 384,448 shares in the last quarter.
Varex Imaging Stock Performance
Shares of VREX traded up $0.10 during midday trading on Friday, reaching $7.84. The stock had a trading volume of 740,752 shares, compared to its average volume of 555,934. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. The firm has a 50 day simple moving average of $11.97 and a 200-day simple moving average of $13.24. The firm has a market cap of $323.01 million, a PE ratio of -6.70 and a beta of 0.65. Varex Imaging Co. has a one year low of $7.33 and a one year high of $17.75.
Varex Imaging (NASDAQ:VREX - Get Free Report) last posted its quarterly earnings results on Thursday, February 6th. The company reported $0.07 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, sell-side analysts anticipate that Varex Imaging Co. will post 0.53 EPS for the current year.
Insider Activity at Varex Imaging
In other news, SVP Kimberley E. Honeysett sold 4,007 shares of the business's stock in a transaction that occurred on Thursday, March 20th. The stock was sold at an average price of $12.81, for a total transaction of $51,329.67. Following the completion of the sale, the senior vice president now owns 4,002 shares in the company, valued at $51,265.62. The trade was a 50.03 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Sunny Sanyal sold 8,749 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total value of $98,338.76. Following the transaction, the chief executive officer now owns 190,193 shares in the company, valued at approximately $2,137,769.32. This trade represents a 4.40 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on VREX shares. Oppenheimer reduced their price objective on shares of Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research note on Friday, February 7th. B. Riley reissued a "buy" rating and set a $22.00 price target (up from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th. Finally, StockNews.com raised Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th.
Get Our Latest Research Report on VREX
About Varex Imaging
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
See Also
Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
